坎託菲茨傑拉德公司：維持Vera Therapeutics評級

證券之星

05-07

坎託菲茨傑拉德公司：維持Vera Therapeutics(VERA.US)評級，由增持調整至增持評級,目標價由107.00美元調整至100.00美元。Vera Therapeutics(VERA.US)公司簡介：Vera Therapeutics Inc是一家臨牀階段的生物技術公司。該公司專注於爲患有嚴重免疫疾病的患者開發變革性療法並將其商業化。該公司的候選產品是atacicept，是一種融合...

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2533930989"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533930989\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2533930989?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-05-07 22:41","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2533930989","market":"us","top_or_hot":-1,"title":"坎託菲茨傑拉德公司：維持Vera Therapeutics評級","media":"證券之星","content":"<div>\n<p>坎託菲茨傑拉德公司：維持Vera Therapeutics(VERA.US)評級，由增持調整至增持評級,目標價由107.00美元調整至100.00美元。Vera Therapeutics(VERA.US)公司簡介：Vera Therapeutics Inc是一家臨牀階段的生物技術公司。該公司專注於爲患有嚴重免疫疾病的患者開發變革性療法並將其商業化。該公司的候選產品是atacicept，是一種融合...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224520a4757e79&s=b\">網頁鏈接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>坎託菲茨傑拉德公司：維持Vera Therapeutics評級</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n坎託菲茨傑拉德公司：維持Vera Therapeutics評級\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">證券之星</strong><span class=\"h-time small\">2025-05-07 22:41</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>坎託菲茨傑拉德公司：維持Vera Therapeutics(VERA.US)評級，由增持調整至增持評級,目標價由107.00美元調整至100.00美元。Vera Therapeutics(VERA.US)公司簡介：Vera Therapeutics Inc是一家臨牀階段的生物技術公司。該公司專注於爲患有嚴重免疫疾病的患者開發變革性療法並將其商業化。該公司的候選產品是atacicept，是一種融合...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224520a4757e79&s=b\">網頁鏈接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224520a4757e79&s=b\">證券之星</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VERA","symbol_name":"Vera Therapeutics, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224520a4757e79&s=b","article_id":"2533930989","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224520a4757e79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2533930989","pubTimestamp":1746628875,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"坎託菲茨傑拉德公司：維持Vera Therapeutics(VERA.US)評級，由增持調整至增持評級,目標價由107.00美元調整至100.00美元。Vera Therapeutics(VERA.US)公司簡介：Vera Therapeutics Inc是一家臨牀階段的生物技術公司。該公司專注於為患有嚴重免疫疾病的患者開發變革性療法並將其商業化。該公司的候選產品是atacicept，是一種融合蛋白，每週皮下注射一次，可阻斷B淋巴細胞刺激劑和增殖誘導配體，它們會刺激B細胞和漿細胞產生導致某些自身免疫性疾病的自身抗體。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["rate"],"viewcount":null,"language":"zh","relate_stocks":{"VERA":"Vera Therapeutics, Inc.","LENZ":"Therapeutics"},"translate_title":"Cantor Fitzgerald: Maintain Vera Therapeutics Rating","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"VERA":1},"content_text":"坎託菲茨傑拉德公司：維持Vera Therapeutics(VERA.US)評級，由增持調整至增持評級,目標價由107.00美元調整至100.00美元。Vera Therapeutics(VERA.US)公司簡介：Vera Therapeutics Inc是一家臨牀階段的生物技術公司。該公司專注於為患有嚴重免疫疾病的患者開發變革性療法並將其商業化。該公司的候選產品是atacicept，是一種融合蛋白，每週皮下注射一次，可阻斷B淋巴細胞刺激劑和增殖誘導配體，它們會刺激B細胞和漿細胞產生導致某些自身免疫性疾病的自身抗體。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}